Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
EPA Issues Partial Ban On Some Flame Retardant, Fuel and Lubricant Chemicals June 28, 2019 Martha Garcia Add Your Comments Four chemicals commonly used in flame retardants, fuels and lubricants may face a partial ban, due to risks they pose to human health.. The U.S. Environmental Protection Agency (EPA) issued a press release on June 21, announcing a proposed rule (PDF) that would result in a nearly full ban on two chemicals, a partial ban on two other chemicals, and no ban on a fifth chemical. The chemicals in question are referred to as persistent bioaccumulative and toxic substances, or PBTs, including: decabromodiphenyl ether (decaBDE) a flame retardant; phenol isopropylated phosphate 3:1 (PIP 3:1) a flame retardant used in consumer products, lubricant, and hydraulic fluid; 2,4,6-tris(tert-butyl) (2,4,6-TTBP) an additive for fuels and lubricants; pentachlorothiophenol (PCTP) is a chemical used to make rubber pliable; hexachlorobutadiene (HCBD) is used as a solvent and hydraulic, heat transfer or transformer fluid. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Each of the chemicals are known to have toxic side effects on humans, and to accumulate in the body. DecaBDE may impact human development, have neurological effects, and is carcinogenic. PIP (3:1) can cause harm to the reproductive system, as well as neurological and developmental effects. 2,4,6-TTBP can potentially effect the liver and human development. Research on PCTP has shown side effects to the liver and reproductive system. The proposed rule would prohibit some actions regarding manufacturing, import, processing, and distribution of the chemicals, except for HCBD. The rule also puts into place record keeping regulations. Most uses of the two flame retardants decaBDE and PIP 3:1 are banned under the proposed rules. The ban also prohibits the processing and distribution of 2,4,6-TTBP for use as an oil or lubricant additive and prevents consumer and business uses of the additive. PCTP would be partially banned; with products containing the chemical in concentrations below 1% by weight being the exception. The agency does not plan to take action on HCBD, despite data indicating the chemical negatively effects development and reproduction and is a possible human carcinogen. The chemicals are subject to fast track action under the 2016 revisions to the Toxic Substances Control Act. In 2016, under the Lautenberg Act, the EPA called for a review and expedited action on 10 chemicals, including some PBTs. The action allowed the EPA to forgo conducting risk evaluations and move to risk management instead. The act calls on the agency to address the risk the chemicals pose to human health or the environment and reduce that exposure. The EPA had a deadline to propose a new rule within 3 years of the Lautenberg Act. To that end, the regulation must be finalized within 18 months of issuing the proposal, or by December 2020. Comments on the proposed regulation will be accepted for 60 days. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Cancer, Chemicals, EPA, Flame Retardants, Toxicity More Lawsuit Stories Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit October 17, 2025 Does Tylenol Cause Autism? A Review of the Science Linking Tylenol and Autism Spectrum Disorder October 17, 2025 J&J Faces Talcum Powder Lawsuit in UK by More Than 3,000 Plaintiffs October 17, 2025 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 2 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025) MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 3 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025) Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 4 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit October 17, 2025
Does Tylenol Cause Autism? A Review of the Science Linking Tylenol and Autism Spectrum Disorder October 17, 2025
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 2 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
MDL Sought for Lyft Lawsuits Over Sexual Assaults by Drivers (Posted: 3 days ago) A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJury Finds Uber Failed To Protect Passengers, But Is Not Liable for Sexual Assault (10/01/2025)Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (09/25/2025)Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: 4 days ago) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)